mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.2 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.3 |